70% to 83%, and resistance to ﬂ  uoroquinolones increased from 78% to 85%. Ten 
per cent of E. coli isolates were resistant to carbapenems in 2008, increasing to 
13% in 2013.3 In one tertiary-care hospital in New Delhi, resistance to carbapenem 
among Klebsiella pneumoniae  increased from 2% in 2002 to 52% in 2009.4 Antibiotic 1. Introduction
2 National Guidelines for Infection Prevention and Control in Healthcare Facilities
use is a major driver of AMR. In 2010, India was the world’s largest consumer of 
antibiotics for human health at 12.9 u 109 units (10.7 units per person).5 
The key global and national initiatives for IPC are given in Box 1.1. The WHO 
Guidelines on Core Components of Infection Control Programmes11 have been